{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:25:51Z","timestamp":1790727951349,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2015.03.024","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T08:13:20Z","timestamp":1442304800000},"page":"2455-2466","source":"Crossref","is-referenced-by-count":163,"title":["Expression of the NLRP3 Inflammasome in Carotid Atherosclerosis"],"prefix":"10.1016","volume":"24","author":[{"given":"Xin","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Li","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Wei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib1","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1007\/s00018-013-1289-1","article-title":"Inflammation and immune system interactions in atherosclerosis","volume":"70","author":"Legein","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35025203","article-title":"Atherosclerosis","volume":"407","author":"Lusis","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib3","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.immuni.2013.06.009","article-title":"Immune effector mechanisms implicated in atherosclerosis: from mice to humans","volume":"38","author":"Libby","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib4","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/nm1102-1218","article-title":"Innate and acquired immunity in atherogenesis","volume":"8","author":"Binder","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1084\/jem.20071096","article-title":"Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events","volume":"205","author":"Mullick","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib6","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1161\/hc5001.100631","article-title":"Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL","volume":"104","author":"Xu","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrmicro2070","article-title":"Pyroptosis: host cell death and inflammation","volume":"7","author":"Bergsbaken","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.tcb.2009.06.002","article-title":"Molecular mechanisms involved in inflammasome activation","volume":"19","author":"Bryant","year":"2009","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib9","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib10","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib11","doi-asserted-by":"crossref","first-page":"791","DOI":"10.5114\/aoms.2014.44871","article-title":"NLRP3 and downstream cytokine expression elevated in the monocytes of patients with coronary artery disease","volume":"10","author":"Wang","year":"2014","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/01.STR.0000150643.08420.78","article-title":"Concurrent treatment with renin-angiotensin system blockers and acetylsalicylic acid reduces nuclear factor kappaB activation and C-reactive protein expression in human carotid artery plaques","volume":"36","author":"Sattler","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib13","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1161\/01.ATV.0000232501.08576.73","article-title":"Dysregulation of the ubiquitin-proteasome system in human carotid atherosclerosis","volume":"26","author":"Versari","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12170-011-0212-2","article-title":"Cholesterol, inflammasomes, and atherogenesis","volume":"6","author":"Ordovas-Montanes","year":"2012","journal-title":"Curr Cardiovasc Risk Rep"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib15","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nri1882","article-title":"The immune response in atherosclerosis: a double-edged sword","volume":"6","author":"Hansson","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib16","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/nri2415","article-title":"The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models","volume":"8","author":"Weber","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib17","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s10875-010-9440-3","article-title":"Molecular mechanism of NLRP3 inflammasome activation","volume":"30","author":"Jin","year":"2010","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib18","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nri3452","article-title":"Activation and regulation of the inflammasomes","volume":"13","author":"Latz","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib19","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1161\/CIRCULATIONAHA.107.746453","article-title":"Critical role of bone marrow apoptosis-associated speck-like protein, an inflammasome adaptor molecule, in neointimal formation after vascular injury in mice","volume":"117","author":"Yajima","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/1753425913484374","article-title":"Caspase-1: the inflammasome and beyond","volume":"20","author":"Sollberger","year":"2014","journal-title":"Innate Immun"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib21","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cjca.2011.10.013","article-title":"Caspase-1 deficiency decreases atherosclerosis in apolipoprotein E-null mice","volume":"28","author":"Gage","year":"2012","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib22","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bbrc.2012.07.058","article-title":"Critical role of caspase-1 in vascular inflammation and development of atherosclerosis in Western diet-fed apolipoprotein E-deficient mice","volume":"425","author":"Usui","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib23","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.ATV.0000064374.15232.C3","article-title":"Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice","volume":"23","author":"Kirii","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib24","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.cardiores.2005.01.008","article-title":"Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice","volume":"66","author":"Merhi-Soussi","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib25","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/hc3901.096721","article-title":"Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability","volume":"104","author":"Mallat","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib26","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.1161\/hh1901.098735","article-title":"Interleukin-18\/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability","volume":"89","author":"Mallat","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib27","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1161\/ATVBAHA.107.149245","article-title":"Free interleukin (IL)-18 levels, and the impact of IL18 and IL18BP genetic variation, in CHD patients and healthy men","volume":"27","author":"Thompson","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib28","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1038\/cddis.2011.18","article-title":"Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome","volume":"2","author":"Menu","year":"2011","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.atherosclerosis.2011.10.032","article-title":"The expression of IGFs and IGF binding proteins in human carotid atherosclerosis, and the possible role of IGF binding protein-1 in the regulation of smooth muscle cell proliferation","volume":"220","author":"Wang","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib30","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1253\/circj.CJ-11-0768","article-title":"Neovascularization and angiogenic factors in advanced human carotid artery stenosis","volume":"76","author":"Pelisek","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib31","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ejvs.2009.12.012","article-title":"A comparative study of carotid atherosclerotic plaque microvessel density and angiogenic growth factor expression in symptomatic versus asymptomatic patients","volume":"39","author":"Chowdhury","year":"2010","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.atherosclerosis.2006.10.038","article-title":"Placenta growth factor expression in human atherosclerotic carotid plaques is related to plaque destabilization","volume":"196","author":"Pilarczyk","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/157340311795677680","article-title":"Atherosclerotic plaque biomarkers: beyond the horizon of the vulnerable plaque","volume":"7","author":"van Lammeren G","year":"2011","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev-physiol-021113-170324","article-title":"Inflammasomes and metabolic disease","volume":"76","author":"Henao-Mejia","year":"2014","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib35","first-page":"16","article-title":"[Inflammation and plaque instability]","volume":"77","author":"Malpartida","year":"2007","journal-title":"Arch Cardiol Mex"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/sca.4950280101","article-title":"Cholesterol crystals rupture biological membranes and human plaques during acute cardiovascular events\u2013a novel insight into plaque rupture by scanning electron microscopy","volume":"28","author":"Abela","year":"2006","journal-title":"Scanning"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib37","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.amjcard.2008.12.019","article-title":"Effect of cholesterol crystals on plaques and intima in arteries of patients with acute coronary and cerebrovascular syndromes","volume":"103","author":"Abela","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2015.03.024_bib38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.atherosclerosis.2008.06.027","article-title":"Physical factors that trigger cholesterol crystallization leading to plaque rupture","volume":"203","author":"Vedre","year":"2009","journal-title":"Atherosclerosis"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305715001366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305715001366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T11:25:39Z","timestamp":1537356339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305715001366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S1052305715001366"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2015.03.024","relation":{},"ISSN":["1052-3057"],"issn-type":[{"value":"1052-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}